Health units in the Federal District of Brazil have started to provide a newly incorporate contraceptive method, the Implanon, which is a subdermal implant releasing etonogestrel and is now available through the Sistema Único de Saúde (SUS). The Brazilian Ministry of Health has distributed approximately 10,000 units of Implanon for this initiative, initially targeting priority groups before expanding access to a larger population once additional supplies are received.

Implanon is categorized as a long-acting reversible contraceptive, similar to the IUD (intrauterine device), and is highly regarded for its effectiveness in reproductive planning. It is especially appreciated since it does not require daily use, which makes it a convenient option for many users. Medical professionals trained in the procedure are responsible for its insertion, which is done under local anesthesia on the inner arm of the patient, ensuring a high level of care and comfort.

The introduction of the Implanon in the Federal District's health units marks a significant advancement in the public health sector's efforts to enhance family planning services. This is particularly important in Brasilia, where access to effective contraceptive methods can considerably benefit those in need, especially within the designated priority groups. The further rollout of this service could lead to improved reproductive health outcomes across the region, addressing both healthcare accessibility and effectiveness issues in contraception.